This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Tsuneaki Yoshida: Innovator in Aminothiazole Derivatives
Introduction
Tsuneaki Yoshida is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of aminothiazole derivatives. His work has implications for the production of important pharmaceutical compounds.
Latest Patents
Yoshida holds a patent for a novel aminothiazoleacetic acid derivative, which serves as an advantageous synthetic intermediate for β-lactam antibiotics. The patent outlines a production method that begins with diketene and involves a specific sequence of steps. This innovation is crucial for enhancing the efficiency of antibiotic synthesis.
Career Highlights
Tsuneaki Yoshida is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on innovative solutions in drug development. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medicinal chemistry.
Collaborations
Yoshida has collaborated with esteemed colleagues such as Kunio Takanohashi and Shoichiro Fujii. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tsuneaki Yoshida's contributions to the field of chemistry, particularly through his patent on aminothiazole derivatives, highlight his role as an innovator in pharmaceutical development. His work continues to influence the production of vital antibiotics, showcasing the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
